Роль мелатонина в нарушениях психоэмоциональной сферы
https://doi.org/10.25789/YMJ.2023.82.26
Аннотация
Проведен анализ отечественной и зарубежной литературы, посвященной изучению влияния мелатонина на психоэмоциональное состояния организма. По мнению большинства исследователей, тенденция к увеличению распространенности депрессивных расстройств сохраняется. В настоящее время идет поиск новых подходов в лечении депрессии. Взаимосвязь между мелатонином и возникновением депрессивных расстройств требует дальнейшего изучения.
Об авторах
А. А. Григорьева
Арктический медицинский центр
Россия
Россия
Анастасия Анатольевна Григорьева, м. н. с.
Якутск
Е. Д. Охлопкова
ФГБНУ ЯНЦ КМП
Россия
Россия
Елена Дмитриевна Охлопкова, к. б. н., с. н. с.
Якутск
Список литературы
1. Доклад о психическом здоровье в мире: oхрана психического здоровья преобразования в интересах всех людей. Краткий обзор https://www.who.int/ru/news/item/28-09-2022-who-and-ilo-call-for-new-measures-to-tackle-mental-health-issues-at-work
2. Пучкова А.Н., Полуэктов М.Г. Сон как биологический ритм: клинические аспекты // Медицинский совет. 2021;(2). С. 56–61. doi: 10.21518/2079-701X-2021-2-56-61
3. Применение мелатонина для профилактики и лечения нарушения циркадных ритмов / А.С. Самойлова, Н.В. Рылова, А.В. Жолинский [и др.] // Практическая медицина. 2021. Т. 19, № 2. С. 34-38. DOI: 10.32000/2072-1757-2021-2-34-38
4. Уровень мелатонина и депрессивные расстройства / А.Н. Васильев, И.В. Кокин, М.О. Комарова // Ведомости Научного центра экспертизы средств медицинского применения. - 2014. № 3. С. 24-29.
5. Analysis of melatonin concentration and its correlation with ovarian disfunction among obese women of reproductive age / R.K. Mikheev, E.N. Andreeva, E.V. Sheremetyeva [et al.] // Problem Endokrinologikol (Mosk). 2022;67(1) P. 69-75. doi: 10.14341/probl12710
6. Antidepressant actions of melatonin and melatonin receptor agonist: focus on pathophysiology and treatment / Wang Y.Q., Jiang Y.J., Zou M.S. [et al.] // Behav. Brain Res., 420 (2022), Article 113724.
7. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis / M. Banasr, A. Soumier, M. Hery [et al.] // Biol. Psychiatry. 59 (2006), pp. 1087-1096.
8. Adult brain neurogenesis and psychiatry: a novel theory of depression / B.L. Jacobs, H. Van Praag, F.H. Gage // Mol. Psychiatry, 5 (2000), pp. 262-269.
9. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives / J.L. Mauriz, P.S. Collado, C. Veneroso [et al.] // J. Pineal Res., 54 (2013), pp. 1-14.
10. Cytokine imbalance in the pathophysiology of major depressive disorder / Y.K. Kim, K.S. Na, K.H. Shin [et al.] // Prog. Neuropsychopharmacol. Biol. Psychiatry, 31 (2007), pp. 1044-1053.
11. Chronic agomelatine treatment prevents comorbid depression in the post-status epilepticus model of acquired epilepsy through suppression of inflammatory signaling / J. Tchekalarova, D. Atanasova, L. Kortenska [et al.] // Neurobiol. Dis., 115 (2018), pp. 127-144.
12. Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment / Szymanska A, Rabe-Jablonska J, Karasek M. // Neuroendocrinol Lett. - 2001; 22 P. 192–198.
13. Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice / E. Kilic, U. Kilic, M. Bacigaluppi [et al.] / J. Pineal. Res., 45 (2008), pp. 142-148.
14. Elevated serum melatonin under constant darkness enhances neural repair in spinal cord injury through regulation of circadian clock proteins expression / Y. Hong, Y. Jin, K. Park [et al.] // J. Clin. Med., 2019;8 (2):p.135. doi: 10.3390/jcm8020135.
15. Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain / E. Tyagi, R. Agrawal, C. Nath [et al.] // Eur. J. Pharmacol., 640 (2010), pp. 206-210.
16. Felger J.C., Lotrich F.E. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications // Neuroscience, 246 (2013), pp. 199-229.
17. Isolation of melatonin, the pineal gland factor that lightens melanocytes / Lerner A., Case J., Takahashi Y. [et al.] // J. Am. Chem. Soc. – 1958. Vol.80. № 10. - P. 2587-2587.
18. Injury switches melatonin production source from endocrine (pineal) to paracrine (phagocytes) - melatonin in human colostrum and colostrum phagocytes / G.N. Pontes, E.C. Cardoso, M.M. Carneiro-Sampaio [et al.] // J. Pineal. Res., 41 (2006), pp. 136-141.
19. Jeon S.W., Kim Y.K. Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness? // World J. Psychiatry, 6 (2016), pp. 283-293.
20. Kim Y.K., Won E. The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder // Behav. Brain Res., 329 (2017), pp. 6-11
21. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression / F.S. Dhabhar, H.M. Burke, E.S. Epel [et al.] // J. Psychiatr. Res., 43 (2009), pp. 962-969.
22. Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care / A. Tarocco, N. Caroccia, G. Morciano [et al.] // Cell Death Dis., 10 (2019), p. 317.
23. Melatonin salvages lead-induced neuro-cognitive shutdown, anxiety, and depressive-like symptoms via oxido-inflammatory and cholinergic mechanisms / N.A. Omeiza, H.A. Abdulrahim, A.I. Alagbonsi [et al.] // Brain Behav., 11 (2021), p. e2227.
24. Melatonin modulates copper-induced anxiety-like, depression-like and memory impairments by acting on hippocampal oxidative stress in rat / M. Lamtai, O. Zghari, S. Azirar [et al.] / Drug Chem. Toxicol. (2021), pp. 1-9.
25. Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation / T. Ali, S.U. Rahman, Q. Hao [et al.] // J. Pineal Res., 69 (2020), p. e12667.
26. Melatonin ameliorates valproic acid-induced neurogenesis impairment: the role of oxidative stress in adult rats / A. Aranarochana, A. Sirichoat, W. Pannangrong [et al.] / Oxid. Med. Cell Longev, - 2021 (2021), Article 9997582.
27. Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism / K. Ding, H. Wang, J. Xu [et al.] // Free Radic. Biol. Med., 73 (2014), pp. 1-11.
28. Melatonin treatment improves the antioxidant status and decreases lipid content in brain and liver of rats / P. Subramanian, S. Mirunalini, S.R. Pandi-Perumal [et al.] // Eur. J. Pharmacol., 571 (2007), pp. 116-119.
29. Melatonin mediates protective effects on inflammatory response induced by interleukin-1 beta in human mesenchymal stem cells / X. Liu, Y. Gong, K. Xiong [et al.] // J. Pineal. Res., 55 (2013), pp. 14-25.
30. Melatonin synergizes with citalopram to induce antidepressant-like behavior and to promote hippocampal neurogenesis in adult mice / G. Ramirez-Rodriguez, N.M. Vega-Rivera, J. Oikawa-Sala [et al.] / J. Pineal. Res., 56 (2014), pp. 450-461.
31. Muller N. Immunology of major depression // Neuroimmunomodulation, 21 (2014), pp. 123-130.
32. Maternally administered melatonin differentially regulates lipopolysaccharide-induced proinflammatory and anti-inflammatory cytokines in maternal serum, amniotic fluid, fetal liver, and fetal brain / D.X. Xu, H. Wang, H. Ning [et al.] // J. Pineal Res., 43 (2007), pp. 74-79.
33. Melatonin act as an antidepressant via attenuation of neuroinflammation by targeting Sirt1/Nrf2/HO-1 Signaling / T. Ali, Q. Hao, N. Ullah [et al.] // Front. Mol. Neurosci., 13 (2020), p. 96.
34. Neuroendocrine aspects of primary endogenous depression / Rubin R.T., Heist E.K., McGeoy S.S. [et al.] // Arch Gen Psychiat. - 1992; 49: С.558-569.
35. Neurological enhancement effects of melatonin against brain injury-induced oxidative stress, neuroinflammation, and neurodegeneration via AMPK/CREB signaling / S.U. Rehman, M. Ikram, N. Ullah [et al.] / Cells, (2019) ;8(7) р. 760.
36. Neuroprotective effect of melatonin on nickel-induced affective and cognitive disorders and oxidative damage in rats / M. Lamtai, S. Ouakki, O. Zghari [et al.] // Environ. Anal. Health Toxicol. - 2020. 35 (4): e2020025-0. doi: 10.5620/eaht.2020025
37. Neuroinflammation and depression: a reviewт / R. Troubat, P. Barone, S. Leman [et al.] // Eur. J. Neurosci., 53 (2021), pp. 151-171.
38. Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice / E.H. Taniguti, Y.S. Ferreira, I.J.V. Stupp [et al.] // Physiol. Behav., 188 (2018), pp. 270-275.
39. Oxidative stress and major depression / Bajpai A., Verma A.K., Srivastava M. [et al.] // Clin. Diagn Res., 8 (2014). P.4-7.
40. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update // J. Clin. Invest., 111 (2003), pp. 1805-1812.
41. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin / R.J. Reiter [et al.] // Biochem. Mol. Biol., 44 (2009), pp. 175-200.
42. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder / T. Frodl, A. Carballedo, M.M. Hughes [et al.] // Transl. Psychiatry, 2 (2012), p. e88.
43. Seasonal affective disorder; a description of the syndrome and preliminary findings with light therapy / Rosenthal N.E., Sack D.A., Gillin J.C. [et al.] // Arch Gen Psychiat. - 1984. - Vol. 41. - P. 72-80.
44. Salim S. Oxidative stress and the central nervous system // J. Pharmacol. Experimental Therapeutics, 360 (2017), pp. 201-205.
45. The importance of melatonin in the regulation of metabolism, eating behavior, sleep, and the prospects for the use of melatonin drugs for obesity treatment / Tsvetkova E.S., Romantsova T.I., Poluektov M.G. [et al.] // Obesity and metabolism. – 2021;18(2) P. 112-124. doi: 10.14341/omet12279
46. The role of oxidative stress in depressive disorders / Michel T.M., Pulschen D., Thome J. // Curr. Pharm. Des., 18 (2012), pp. 5890-5899.
47. Targeting free radicals in oxidative stress-related human diseases / Poprac P., Jomova K., Simunkova M. [et al.] // Trends Pharmacol. Sci., 38 (2017), pp. 592-607.
48. The changing faces of glutathione, a cellular protagonist / A. Pompella, A. Visvikis, A. Paolicchi [et al.] // Casini Biochem. Pharmacol., 66 (2003), pp. 1499-1503.
49. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression / Y.K. Kim, K.S. Na, A.M. Myint [et al.] // Prog. Neuropsychopharmacol. Biol. Psychiatry, 64 (2016), pp. 277-284.
Рецензия
Для цитирования:
Григорьева А.А., Охлопкова Е.Д. Роль мелатонина в нарушениях психоэмоциональной сферы. Якутский медицинский журнал. 2023;(2):112-115. https://doi.org/10.25789/YMJ.2023.82.26
For citation:
Grigorieva A.A., Okhlopkova E.D. The role of melatonin in disorders of the psychoemotional sphere. Yakut Medical Journal. 2023;(2):112-115. https://doi.org/10.25789/YMJ.2023.82.26
Просмотров:
33
Послать статью по эл. почте 